DaVita Drops Sharply on Heavy Volume with No Clear Catalyst
The healthcare company posted its sixth-largest drop of the year on elevated volume, while our sources show no fresh catalyst and EasyAlpha maintains an average C grade.
EasyAlpha Research · Sep 17, 2026 · Sep 17, 6:46 PM EDTPlus
DVA · DaVita HealthCare Partners Inc
$183.24-5.5%
Average quality
Our grade
52-week range
- Our read: EasyAlpha grades DaVita HealthCare Partners Inc C, pointing to an average quality profile among Healthcare peers in the S&P 500, where solid growth is counterbalanced by its debt load.
- The day: Shares fell 5.5% to close at $183.24 on 2.3x average volume, marking the stock's sixth-largest drop over the past year, with our sources showing no reported driver.
- Watching: The next quarterly earnings report, scheduled for release on Wednesday, November 4.
Shares of DaVita HealthCare Partners Inc fell 5.5% on Thursday, September 17, finishing at $183.24. Trading was unusually heavy, with volume reaching 2.3x the 20-session average. The decline represented the stock's sharpest single-day retreat since Wednesday, August 5.
Our sources show no reported company-specific driver behind the sharp move. The company posted no press releases or corporate announcements during the session. The drop occurred even as broader equity markets advanced while Treasury yields eased.
EasyAlpha grades DVA C, indicating typical quality relative to its Healthcare peers in the S&P 500. Across EasyAlpha's research, companies graded A or B have stronger fundamentals and historically carry a lower risk of large drawdowns than companies graded D or E, while a C grade denotes an average company for its industry.
Fundamental results continue to show steady operational traction. Growth stands out as the company's main strength, supported by quarterly revenue growth of +5.2% year over year. DaVita generates an 88.5% return on equity across its healthcare operations. Even after Thursday's slide, the stock is +61.3% so far this year.
The primary watch item in DaVita's file is its debt load. At Thursday's close, the stock trades at 10.3 times forward earnings, sitting 26.0% below its 52-week high.
Wall Street sentiment remains divided. Across seven analysts covering the stock, 42.9% rate it a buy, with an average price target of $219.86. The company's next scheduled corporate milestone arrives on Wednesday, November 4, when DaVita reports quarterly earnings.
See everything we know about DVA
The full grade breakdown, the numbers behind it, the chart and the news, updated every day.
How grades work
Every day we grade each company against the other companies in its sector, looking at its finances, how its stock trades, and what the market is signaling. The result is one simple letter.
- AExcellent quality
- BGood quality
- CAverage quality
- DBelow average
- EWeakest quality
A grade measures quality against the other companies in a sector, from historical data. It is not a prediction, not a price target, and not advice. A company can be graded A and still fall.